Asynchronous termination of these drivers after birth would lead to a biphasic postnatal dysregulation of IGF-1 tone in the infant, with the early insulin resistance-driven overgrowth in the first life year coinciding with the well-documented and specific accelerated development and growth in ASD. The gene discussed is IGF1; the disease is Insulin resistance.